UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (2219) 2219
life sciences & biomedicine (2170) 2170
humans (2088) 2088
biological and medical sciences (1983) 1983
medical sciences (1961) 1961
psychology. psychoanalysis. psychiatry (1791) 1791
male (1783) 1783
female (1492) 1492
pharmacology. drug treatments (1478) 1478
neuropharmacology (1340) 1340
psychiatry (1318) 1318
psychopharmacology (1300) 1300
psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (1216) 1216
adult (1126) 1126
neurosciences & neurology (1037) 1037
psychopathology. psychiatry (962) 962
adult and adolescent clinical studies (882) 882
neurosciences (873) 873
mood disorders (844) 844
middle aged (827) 827
pharmacology & pharmacy (734) 734
animals (731) 731
depression (698) 698
psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer (575) 575
clinical neurology (435) 435
aged (433) 433
rats (412) 412
adolescent (367) 367
dose-response relationship, drug (356) 356
mood disorders - chemically induced (333) 333
treatment outcome (309) 309
risk factors (306) 306
psychology (298) 298
double-blind method (295) 295
depressive disorder - drug therapy (293) 293
social sciences (291) 291
antidepressants (289) 289
bipolar disorder - drug therapy (280) 280
neurology (280) 280
disease models, animal (260) 260
depression, mental (256) 256
mood (252) 252
antidepressive agents - adverse effects (242) 242
mice (240) 240
psychiatric status rating scales (240) 240
depression - chemically induced (225) 225
bipolar disorder (223) 223
antidepressive agents - therapeutic use (222) 222
time factors (208) 208
antipsychotic agents - adverse effects (207) 207
anxiety (207) 207
fundamental and applied biological sciences. psychology (205) 205
serotonin uptake inhibitors - adverse effects (203) 203
mood disorders - drug therapy (200) 200
young adult (196) 196
drug therapy (192) 192
abridged index medicus (191) 191
drug therapy, combination (186) 186
analysis (185) 185
behavioral sciences (171) 171
mental depression (168) 168
research (167) 167
bipolar disorder - chemically induced (164) 164
serotonin uptake inhibitors - therapeutic use (162) 162
antipsychotic agents - therapeutic use (161) 161
nervous system (160) 160
psychology, clinical (156) 156
drug administration schedule (155) 155
miscellaneous (152) 152
rats, wistar (152) 152
depressive disorder, major - drug therapy (148) 148
rats, sprague-dawley (145) 145
bipolar disorders (141) 141
depressive disorder - psychology (139) 139
psychology. psychophysiology (139) 139
analysis of variance (136) 136
behavior, animal - drug effects (134) 134
motor activity - drug effects (134) 134
pregnancy (134) 134
toxicology (134) 134
schizophrenia (133) 133
mental disorders (132) 132
child (131) 131
serotonin (131) 131
anxiety - chemically induced (129) 129
brain - drug effects (127) 127
drug toxicity and drugs side effects treatment (126) 126
retrospective studies (125) 125
psycholeptics: tranquillizer, neuroleptic (124) 124
bipolar disorder - psychology (123) 123
cognition disorders - chemically induced (123) 123
depressive disorder - chemically induced (122) 122
behavioral psychophysiology (119) 119
care and treatment (115) 115
depression - drug therapy (114) 114
severity of illness index (114) 114
health aspects (113) 113
prospective studies (113) 113
lithium (112) 112
mania (112) 112
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2703) 2703
French (18) 18
German (9) 9
Polish (8) 8
Japanese (7) 7
Spanish (5) 5
Portuguese (4) 4
Russian (4) 4
Dutch (3) 3
Hungarian (2) 2
Turkish (2) 2
Finnish (1) 1
Korean (1) 1
Serbian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CA: a cancer journal for clinicians, ISSN 0007-9235, 07/2013, Volume 63, Issue 4, pp. 249 - 279
Journal Article
Experimental neurology, ISSN 0014-4886, 2008, Volume 213, Issue 1, pp. 71 - 83
Learning and memory | Hippocampal sclerosis | Depression | Anxiety | Psychopathology | Glutamate | Seizures | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy | Neurology | Biological and medical sciences | Medical sciences | Nervous system (semeiology, syndromes) | Epilepsy, Temporal Lobe - psychology | Memory Disorders - physiopathology | Nerve Degeneration - physiopathology | Status Epilepticus - chemically induced | Epilepsy, Temporal Lobe - physiopathology | Learning Disorders - physiopathology | Hippocampus - drug effects | Dentate Gyrus - physiopathology | Nerve Degeneration - chemically induced | Dentate Gyrus - drug effects | Female | Depressive Disorder - chemically induced | Disease Models, Animal | Mood Disorders - chemically induced | Mental Disorders - chemically induced | Epilepsy, Temporal Lobe - chemically induced | Kainic Acid - pharmacology | Status Epilepticus - pathology | Neurocognitive Disorders - physiopathology | Excitatory Amino Acid Agonists - pharmacology | Hippocampus - pathology | Neurocognitive Disorders - chemically induced | Maze Learning - drug effects | Nerve Degeneration - pathology | Mental Disorders - physiopathology | Neuropsychological Tests | Learning Disorders - chemically induced | Animals | Depressive Disorder - physiopathology | Status Epilepticus - physiopathology | Convulsants - pharmacology | Mice | Mood Disorders - physiopathology | Dentate Gyrus - pathology | Hippocampus - physiopathology | Memory Disorders - chemically induced | Temporal lobe epilepsy | Index Medicus
Journal Article
Journal of child psychology and psychiatry, ISSN 0021-9630, 03/2013, Volume 54, Issue 3, pp. 227 - 246
ADHD | medication | adverse events | European | management | recommendations | Social Sciences | Life Sciences & Biomedicine | Psychology, Developmental | Psychiatry | Psychology | Science & Technology | Therapy | Behavior Disorders | Europe | Drug Therapy | Risk | Foreign Countries | Suicide | Substance Abuse | Patients | Scientific Research | Incidence | Guidelines | Physical Development | Outcomes of Treatment | Sleep | Attention Deficit Hyperactivity Disorder | Literature Reviews | Meta Analysis | Symptoms (Individual Disorders) | Eating Habits | Seizures | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer | Psychology. Psychoanalysis. Psychiatry | Attention deficit disorders. Hyperactivity | Psychopharmacology | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Biological and medical sciences | Medical sciences | Neuropharmacology | Drug toxicity and drugs side effects treatment | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) | Child clinical studies | Sleep Wake Disorders - chemically induced | Tic Disorders - therapy | Cardiovascular Diseases - prevention & control | Humans | Suicide - prevention & control | Dextroamphetamine - adverse effects | Seizures - chemically induced | Heart Rate - drug effects | Lisdexamfetamine Dimesylate | Central Nervous System Stimulants - adverse effects | Guanfacine - adverse effects | Atomoxetine Hydrochloride | Blood Pressure - drug effects | Child | Methylphenidate - administration & dosage | Substance-Related Disorders - etiology | Growth Disorders - chemically induced | Body Size - drug effects | Psychoses, Substance-Induced | Sleep Wake Disorders - therapy | Clonidine - adverse effects | Treatment Outcome | Methylphenidate - adverse effects | Seizures - therapy | Substance-Related Disorders - therapy | Attention Deficit Disorder with Hyperactivity - drug therapy | Propylamines - administration & dosage | Adolescent | Tic Disorders - chemically induced | Cardiovascular Diseases - chemically induced | Propylamines - adverse effects | Side effects | Drug therapy | Children & youth | Best practice | Index Medicus
Journal Article
Addiction biology, ISSN 1355-6215, 06/2008, Volume 13, Issue 2, pp. 264 - 275
cannabis | initial prodromal state | bipolar disorder | Anxiety | schizophrenia | major depression | Schizophrenia | Bipolar disorder | Cannabis | Initial prodromal state | Major depression | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Substance Abuse | Science & Technology | Psychoses, Substance-Induced - psychology | Antipsychotic Agents - toxicity | Bipolar Disorder - chemically induced | Marijuana Abuse - psychology | Mood Disorders - psychology | Cognition Disorders - chemically induced | Humans | Bipolar Disorder - physiopathology | Anxiety Disorders - chemically induced | Cannabinoid Receptor Modulators - physiology | Drug Interactions | Psychoses, Substance-Induced - physiopathology | Schizophrenia - physiopathology | Cannabinoids - toxicity | Marijuana Abuse - physiopathology | Cognition Disorders - psychology | Mood Disorders - chemically induced | Depressive Disorder, Major - physiopathology | Schizophrenia - chemically induced | Affect - drug effects | Cognition Disorders - physiopathology | Affect - physiology | Brain - physiopathology | Risk Factors | Anxiety Disorders - psychology | Bipolar Disorder - psychology | Brain - drug effects | Depressive Disorder, Major - chemically induced | Depressive Disorder, Major - psychology | Animals | Signal Transduction - drug effects | Receptor, Cannabinoid, CB1 - drug effects | Signal Transduction - physiology | Mood Disorders - physiopathology | Dronabinol - toxicity | Anxiety Disorders - physiopathology | Marijuana | Index Medicus
Journal Article